Evaluation of the Efficacy and Safety of Intravenous Immunoglobulin (IVIG) in Moderate-to-Severe Hospitalized COVID-19 Patients: A Randomized, Open-Label Parallel-Group Study

Table 3

Chest radiograph findings and their comparison between groups.

Chest x-ray parameters	IVIG + SoC (Day 1)		IVIG + SoC (Day 9)		value	SoC (Day 1)		SoC (Day 9)		value
Number	33					26
Ground glass opacities (GGO)	33	100.00%	29	87.88%	0.0406	26	100%	26	100%	—
Consolidation	30	90.91%	29	87.88%	0.6916	24	92%	24	92%	—
Central	16	48.48%	8	24.24%	0.0422	20	77%	18	69%	0.5199
Peripheral	33	100.00%	29	87.88%	0.0406	26	100%	25	96%	0.3076
Apical	15	45.45%	9	27.27%	0.1276	18	69%	14	54%	0.2710
Basal	32	96.97%	26	78.79%	0.0247	26	100%	26	100%	—
Hilar lymphadenopathy	9	27.27%	8	24.24%	0.7800	5	19%	5	19%	—
Pleural effusion	13	39.39%	3	9.09%	0.0044	12	46%	7	27%	0.1588

Bold values denote significant P-values (≤0.05).